Evidence map›Paper›PMID 35274480›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Continuous Additive Manufacturing using Olefin Metathesis.

Jeffrey C Foster, Adam W Cook, Nicolas T Monk, Brad H Jones, Leah N Appelhans, Erica M Redline, Samuel C Leguizamon

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Volumetric Additive Manufacturing of Dicyclopentadiene by Solid-State Photopolymerization.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Review
  7. Continuous Additive Manufacturing using Olefin Metathesis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jeffrey C FosterSandia National Laboratories, Albuquerque, NM, 87185, USA.ORCID 0000-0002-9097-8680
Adam W CookSandia National Laboratories, Albuquerque, NM, 87185, USA.ORCID 0000-0003-0695-1520
Nicolas T MonkSandia National Laboratories, Albuquerque, NM, 87185, USA.
Brad H JonesSandia National Laboratories, Albuquerque, NM, 87185, USA.ORCID 0000-0003-3674-9075
Leah N AppelhansSandia National Laboratories, Albuquerque, NM, 87185, USA.ORCID 0000-0002-2135-9173
Erica M RedlineSandia National Laboratories, Albuquerque, NM, 87185, USA.ORCID 0000-0003-4332-012X
Samuel C LeguizamonSandia National Laboratories, Albuquerque, NM, 87185, USA.ORCID 0000-0003-3395-6562

Funding

Laboratory Directed Research and DevelopmentSandia National LaboratoriesU.S. Department of EnergyU.S. Department of Energy's National Nuclear Security Administration DE-NA-0003525
6 · The paper itself

Abstract

The development of chemistry is reported to implement selective dual-wavelength olefin metathesis polymerization for continuous additive manufacturing (AM). A resin formulation based on dicyclopentadiene is produced using a latent olefin metathesis catalyst, various photosensitizers (PSs) and photobase generators (PBGs) to achieve efficient initiation at one wavelength (e.g., blue light) and fast catalyst decomposition and polymerization deactivation at a second (e.g., UV-light). This process enables 2D stereolithographic (SLA) printing, either using photomasks or patterned, collimated light. Importantly, the same process is readily adapted for 3D continuous AM, with printing rates of 36 mm h

Indexed as

AlkenesPrinting, Three-DimensionalCatalysisLightPolymerizationAlkenesadditive manufacturingdual-wavelengtholefin metathesisphotosensitizerstereolithography

Identifiers

PMID35274480
PMCPMC9108613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.